Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells
Researchers demonstrate enhanced loss-of-function editing of CRISPR/Cas9 in human cells.
Yurchanka Siarhei Shutterstock Molecular Therapy Nucleic Acids Yurchanka Siarhei Augmented Cas Genome Editing
Source: news-medical.net